These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18599803)

  • 1. Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes.
    Ito T; Kawahara K; Okamoto K; Yamada S; Yasuda M; Imaizumi H; Nawa Y; Meng X; Shrestha B; Hashiguchi T; Maruyama I
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1825-30. PubMed ID: 18599803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic Expression of Human Thrombomodulin Inhibits HMGB1-Induced Porcine Aortic Endothelial Cell Activation.
    Bongoni AK; Klymiuk N; Wolf E; Ayares D; Rieben R; Cowan PJ
    Transplantation; 2016 Sep; 100(9):1871-9. PubMed ID: 27077599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulants.
    Tsubota M; Fukuda R; Hayashi Y; Miyazaki T; Ueda S; Yamashita R; Koike N; Sekiguchi F; Wake H; Wakatsuki S; Ujiie Y; Araki T; Nishibori M; Kawabata A
    J Neuroinflammation; 2019 Oct; 16(1):199. PubMed ID: 31666085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism.
    Abeyama K; Stern DM; Ito Y; Kawahara K; Yoshimoto Y; Tanaka M; Uchimura T; Ida N; Yamazaki Y; Yamada S; Yamamoto Y; Yamamoto H; Iino S; Taniguchi N; Maruyama I
    J Clin Invest; 2005 May; 115(5):1267-74. PubMed ID: 15841214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombomodulin improved liver injury, coagulopathy, and mortality in an experimental heatstroke model in mice.
    Kawasaki T; Okamoto K; Kawasaki C; Sata T
    Anesth Analg; 2014 May; 118(5):956-63. PubMed ID: 24781566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Thrombin in Soluble Thrombomodulin-Induced Suppression of Peripheral HMGB1-Mediated Allodynia in Mice.
    Tsujita R; Tsubota M; Hayashi Y; Saeki H; Sekiguchi F; Kawabata A
    J Neuroimmune Pharmacol; 2018 Jun; 13(2):179-188. PubMed ID: 29196860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia.
    Nagato M; Okamoto K; Abe Y; Higure A; Yamaguchi K
    Crit Care Med; 2009 Jul; 37(7):2181-6. PubMed ID: 19487933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-mobility group box 1 protein promotes development of microvascular thrombosis in rats.
    Ito T; Kawahara K; Nakamura T; Yamada S; Nakamura T; Abeyama K; Hashiguchi T; Maruyama I
    J Thromb Haemost; 2007 Jan; 5(1):109-16. PubMed ID: 17239166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High mobility group B1 levels in sepsis and Disseminated Intravascular Coagulation.
    Eskici ZM; Açıkgöz Ş; Pişkin N; Mungan G; Can M; Güven B; Köktürk F
    Acta Biochim Pol; 2012; 59(4):561-6. PubMed ID: 23094260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Thrombomodulin Modulates Murine Colitis Possibly via High-Mobility Group Box 1 Protein Inhibition.
    Ueda T; Higashiyama M; Narimatsu K; Yasutake Y; Kurihara C; Okada Y; Watanabe C; Yoshikawa K; Maruta K; Komoto S; Tomita K; Nagao S; Hokari R; Miura S
    Digestion; 2015; 92(2):108-19. PubMed ID: 26302768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous HMGB1 is required in endotoxin tolerance.
    Li S; Luo C; Yin C; Peng C; Han R; Zhou J; He Q; Zhou J
    J Surg Res; 2013 Nov; 185(1):319-28. PubMed ID: 23866790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial.
    Yamato M; Minematsu Y; Fujii J; Mori K; Minato T; Miyagawa S; Fujimura R; Morikage N; Arata Y; Nakano C; Wada A; Ito T
    Ther Apher Dial; 2013 Oct; 17(5):472-6. PubMed ID: 24107274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of thrombin and CD40 ligand on endothelial matrix metalloproteinase-10 expression and microparticle generation in vitro and in vivo.
    Martínez de Lizarrondo S; Roncal C; Calvayrac O; Rodríguez C; Varo N; Purroy A; Lorente L; Rodríguez JA; Doeuvre L; Hervás-Stubbs S; Angles-Cano E; Páramo JA; Martínez-González J; Orbe J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1477-87. PubMed ID: 22492089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombomodulin's lectin-like domain reduces myocardial damage by interfering with HMGB1-mediated TLR2 signalling.
    Herzog C; Lorenz A; Gillmann HJ; Chowdhury A; Larmann J; Harendza T; Echtermeyer F; Müller M; Schmitz M; Stypmann J; Seidler DG; Damm M; Stehr SN; Koch T; Wollert KC; Conway EM; Theilmeier G
    Cardiovasc Res; 2014 Mar; 101(3):400-10. PubMed ID: 24323314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sepsis and disseminated intravascular coagulation.
    Okamoto K; Tamura T; Sawatsubashi Y
    J Intensive Care; 2016; 4():23. PubMed ID: 27011792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baicalin inhibits high-mobility group box 1 release and improves survival in experimental sepsis.
    Wang H; Liu D
    Shock; 2014 Apr; 41(4):324-30. PubMed ID: 24430548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant thrombomodulin ameliorates experimental autoimmune encephalomyelitis by suppressing high mobility group box 1 and inflammatory cytokines.
    Uzawa A; Mori M; Masuda H; Ohtani R; Uchida T; Kuwabara S
    Clin Exp Immunol; 2018 Jul; 193(1):47-54. PubMed ID: 29509323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombomodulin accelerates activated protein C production and inhibits thrombin generation in the plasma of disseminated intravascular coagulation patients.
    Wada H; Sakakura M; Kushiya F; Nisikawa M; Onishi K; Nakatani K; Shiku H; Nobori T
    Blood Coagul Fibrinolysis; 2005 Jan; 16(1):17-24. PubMed ID: 15650541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of thrombomodulin lectin-like domain in inflammation.
    Li YH; Kuo CH; Shi GY; Wu HL
    J Biomed Sci; 2012 Mar; 19(1):34. PubMed ID: 22449172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombomodulin as a Physiological Modulator of Intravascular Injury.
    Watanabe-Kusunoki K; Nakazawa D; Ishizu A; Atsumi T
    Front Immunol; 2020; 11():575890. PubMed ID: 33042158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.